Susquehanna International »

Tvardi Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2026-06-30 $63k 33k 1.90

More positions owned by Susquehanna International

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Sandisk Corp (SNDK)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)

View all positions for Susquehanna International

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Capital Management
American Financial Group
UBS Group
Silvercrest Asset Management Group
State Street Corporation
BlackRock
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Duncan Williams Asset Management
Vanguard Fiduciary Trust
Russell Investments
Susquehanna International
AQR Capital Management

View all funds holding Tvardi Therapeutics